The use of a food supplementation with D-phenylalanine, L-glutamine and L-5-hydroxytriptophan in the alleviation of alcohol withdrawal symptoms;Upotreba suplementacije hrane sa D-fenilalaninom, L-glutaminom i L-5-hidroksitriptofanom u olakšavanju simptoma susprezanja od alkohola

Collegium Antropologicum

Volumn 35, Issue 4, 2011, Pages 1225-1230

  Jukić, Tomislav ^a   Rojc, Bojan ^b   Boben Bardutzky, Darja ^c   Hafner, Mateja ^d   Ihan, Alojz ^e  

^a JOSIP JURAJ STROSSMAYER UNIVERSITY OF OSIJEK   (Croatia)

^b Hospital Izola   (Slovenia)

^c Vojnik Psyhiatric Hospital   (Slovenia)

^d Institute for Preventive Medicine   (Slovenia)

^e UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Alcohol withdrawal; Cortisol; D phenylalanine; Stress

Indexed keywords

5 HYDROXYTRYPTOPHAN; BILIRUBIN; GLUTAMINE; HYDROCORTISONE; PHENYLALANINE;

ALCOHOLISM; ARTICLE; BLOOD; CD4+ T LYMPHOCYTE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; HUMAN; IMMUNOLOGY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; WITHDRAWAL SYNDROME;

5-HYDROXYTRYPTOPHAN; ALCOHOLISM; BILIRUBIN; CD4-POSITIVE T-LYMPHOCYTES; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; GLUTAMINE; HUMANS; HYDROCORTISONE; PHENYLALANINE; PROSPECTIVE STUDIES; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84855555655     PISSN: 03506134     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. GOLDMAN D, OROSZI G, DUCCI F, Nat Rev Genet, 6 (2005) 521.
2. BENCEVIĆ-STRIEHL H, MALATESTINIĆ D, VULETIĆ S, Coll Antropol, 33 (2009) 39.
3. KEZIĆ S, MIHANOVIĆ M, ZILIĆ-DZEBA J, SAIN I, Coll Antropol, 29 (2005) 533.
4. SCHULTZ W, Neuron, 36 (2002) 241.
5. KELLEY AE, BERRIDGE KC, J Neurosci, 22 (2002) 3306.
6. MOKROVIĆ G, MATOSIĆ A, HRANILOVIĆ D, STEFULJ J, NOVOKMET M, ORESKOVIĆ D, BALIJA M, MARUSIĆ S, CICIN-SAIN L, Coll Antropol, 32 (2008) 127.
7. LINGFORD-HUGHES A, NUTT D, Br J Psychiatry, 182 (2003) 97.
8. VERMETTEN E, BREMNER JD, Depress Anxiety, 16 (2002) 14.
9. RUSSELL AL, MCCARTY MF, Med Hypotheses, 55 (2000) 283.
10. TRACHTENBERG MC, BLUM K, The American Journal of Drug and Alcohol Abuse, 13 (1987) 365.
11. WISE RA, Neuron, 36 (2002) 229.
12. AHMED SH, Science, 306 (2004) 1901.
13. BLUM K, United States Patent 4, 761, 429.
14. CHEN TJ, BLUM K, PAYTE JT, SCHOOLFIELD J, HOPPER D, STANFORD M, BRAVERMAN ER, Med Hypotheses, 63 (2004) 538.
15. ZALEWSKA-KASZUBSKA J, CZARNECKA E, Peptides, 26 (2005)701.
16. OSWALD LM, WAND GS, Physiol Behav, 81 (2004)339.
17. ADACHI Y, BRADFORD BU, GAO W, BOJES HK, THURMAN RG, Hepatology, 20 (1994) 453.
18. BOYADJIEVA N, DOKUR M, ADVIS JP, MEADOWS GG, SARKAR DK, J Immunol, 167 (2001) 5645.
19. DAWSON DA, Addiction, 89 (1994) 345.
20. HADDAD JJ, SAADE NE, SAFIEH-GARABEDIAN B, J Neuroimmunol, 133 (2002) 1.